Cargando…

Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1

As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hui, Yan, Yufei, Jia, Peng, Yang, Kai, Guo, Changjun, Chen, Hao, Qi, Jin, Qian, Niandong, Xu, Xing, Wang, Fei, Li, Changwei, Guo, Lei, Deng, Lianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133998/
https://www.ncbi.nlm.nih.gov/pubmed/27787522
http://dx.doi.org/10.1038/cddis.2016.339
_version_ 1782471386442235904
author Kang, Hui
Yan, Yufei
Jia, Peng
Yang, Kai
Guo, Changjun
Chen, Hao
Qi, Jin
Qian, Niandong
Xu, Xing
Wang, Fei
Li, Changwei
Guo, Lei
Deng, Lianfu
author_facet Kang, Hui
Yan, Yufei
Jia, Peng
Yang, Kai
Guo, Changjun
Chen, Hao
Qi, Jin
Qian, Niandong
Xu, Xing
Wang, Fei
Li, Changwei
Guo, Lei
Deng, Lianfu
author_sort Kang, Hui
collection PubMed
description As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for the treatment of wear particles-induced osteolysis. In the present study, we demonstrated for the first time that desferrioxamine (DFO), a powerful iron chelator, could significantly alleviate osteolysis in an ultrahigh-molecular-weight polyethylene (UHMWPE) particles-induced mice calvaria osteolysis model. Furthermore, DFO attenuated calvaria osteolysis by restraining enhanced inflammatory osteoclastogenesis induced by UHMWPE particles. Consistent with the in vivo results, we found DFO was also able to inhibit osteoclastogenesis in a dose-dependent manner in vitro, as evidenced by reduction of osteoclasts formation and suppression of osteoclast specific genes expression. In addition, DFO dampened osteoclasts differentiation and formation at early stage but not at late stage. Mechanistically, the reduction of osteoclastogenesis by DFO was due to increased heme oxygenase-1 (HO-1) expression, as decreased osteoclasts formation induced by DFO was significantly restored after HO-1 was silenced by siRNA, while HO-1 agonist COPP treatment enhanced DFO-induced osteoclastogenesis inhibition. In addition, blocking of p38 mitogen-activated protein kinase (p38MAPK) signaling pathway promoted DFO-induced HO-1 expression, implicating that p38 signaling pathway was involved in DFO-mediated HO-1 expression. Taken together, our results suggested that DFO inhibited UHMWPE particles-induced osteolysis by restraining inflammatory osteoclastogenesis through upregulation of HO-1 via p38MAPK pathway. Thus, DFO might be used as an innovative and safe therapeutic alternative for treating wear particles-induced aseptic loosening.
format Online
Article
Text
id pubmed-5133998
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51339982016-12-16 Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 Kang, Hui Yan, Yufei Jia, Peng Yang, Kai Guo, Changjun Chen, Hao Qi, Jin Qian, Niandong Xu, Xing Wang, Fei Li, Changwei Guo, Lei Deng, Lianfu Cell Death Dis Original Article As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for the treatment of wear particles-induced osteolysis. In the present study, we demonstrated for the first time that desferrioxamine (DFO), a powerful iron chelator, could significantly alleviate osteolysis in an ultrahigh-molecular-weight polyethylene (UHMWPE) particles-induced mice calvaria osteolysis model. Furthermore, DFO attenuated calvaria osteolysis by restraining enhanced inflammatory osteoclastogenesis induced by UHMWPE particles. Consistent with the in vivo results, we found DFO was also able to inhibit osteoclastogenesis in a dose-dependent manner in vitro, as evidenced by reduction of osteoclasts formation and suppression of osteoclast specific genes expression. In addition, DFO dampened osteoclasts differentiation and formation at early stage but not at late stage. Mechanistically, the reduction of osteoclastogenesis by DFO was due to increased heme oxygenase-1 (HO-1) expression, as decreased osteoclasts formation induced by DFO was significantly restored after HO-1 was silenced by siRNA, while HO-1 agonist COPP treatment enhanced DFO-induced osteoclastogenesis inhibition. In addition, blocking of p38 mitogen-activated protein kinase (p38MAPK) signaling pathway promoted DFO-induced HO-1 expression, implicating that p38 signaling pathway was involved in DFO-mediated HO-1 expression. Taken together, our results suggested that DFO inhibited UHMWPE particles-induced osteolysis by restraining inflammatory osteoclastogenesis through upregulation of HO-1 via p38MAPK pathway. Thus, DFO might be used as an innovative and safe therapeutic alternative for treating wear particles-induced aseptic loosening. Nature Publishing Group 2016-10 2016-10-27 /pmc/articles/PMC5133998/ /pubmed/27787522 http://dx.doi.org/10.1038/cddis.2016.339 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Kang, Hui
Yan, Yufei
Jia, Peng
Yang, Kai
Guo, Changjun
Chen, Hao
Qi, Jin
Qian, Niandong
Xu, Xing
Wang, Fei
Li, Changwei
Guo, Lei
Deng, Lianfu
Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title_full Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title_fullStr Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title_full_unstemmed Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title_short Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
title_sort desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133998/
https://www.ncbi.nlm.nih.gov/pubmed/27787522
http://dx.doi.org/10.1038/cddis.2016.339
work_keys_str_mv AT kanghui desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT yanyufei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT jiapeng desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT yangkai desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT guochangjun desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT chenhao desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT qijin desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT qianniandong desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT xuxing desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT wangfei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT lichangwei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT guolei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1
AT denglianfu desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1